Rabbit and Rodent Ophthalmology
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Surgically Induced Scleral Staphyloma
Original Article Surgically induced scleral staphyloma Yong Yao1, Ming-Zhi Zhang1, Vishal Jhanji1,2 1Joint International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China; 2Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China Contributions: (I) Conception and design: Y Yao; (II) Administrative support: MZ Zhang; (III) Provision of study materials or patients: Y Yao; (IV) Collection and assembly of data: Y Yao; (V) Data analysis and interpretation: Y Yao; V Jhanji; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Yong Yao. Shantou International Eye Center, Jinping District, Guangxia New Town, Shantou 515041, China. Email: [email protected] or [email protected]. Background: To report the clinical features of surgically induced scleral staphyloma and investigate the management. Methods: Retrospective uncontrolled study. Results: A full ophthalmological evaluation of surgically induced scleral staphyloma in four patients was performed. The first patient was a 3-year-old young girl underwent corneal dermoid resection. The second patient was a 60-year-old man underwent nasal pterygium excision and conjunctival autograft without Mitomycin C (MMC). The other two were respectively a 74-year-old woman and a 69-year-old man underwent cataract surgery. All patients performed allogeneic sclera patch graft. In the at least half a year follow-up, the best corrected visual acuity (BCVA) of all the four patients were no worse than that of preoperative. Ocular symptoms disappeared, including eye pain, foreign body sensation, and so on. Unfortunately, the fourth patient showed sclera rejection and partial dissolution at postoperative 1 month. -
Megalocornea Jeffrey Welder and Thomas a Oetting, MS, MD September 18, 2010
Megalocornea Jeffrey Welder and Thomas A Oetting, MS, MD September 18, 2010 Chief Complaint: Visual disturbance when changing positions. History of Present Illness: A 60-year-old man with a history of simple megalocornea presented to the Iowa City Veterans Administration Healthcare System eye clinic reporting visual disturbance while changing head position for several months. He noticed that his vision worsened with his head bent down. He previously had cataract surgery with an iris-sutured IOL due to the large size of his eye, which did not allow for placement of an anterior chamber intraocular lens (ACIOL) or scleral-fixated lens. Past Medical History: Megalocornea Medications: None Family History: No known history of megalocornea Social History: None contributory Ocular Exam: • Visual Acuity (with correction): • OD 20/100 (cause unknown) • OS 20/20 (with upright head position) • IOP: 18mmHg OD, 17mmHg OS • External Exam: normal OU • Pupils: No anisocoria and no relative afferent pupillary defect • Motility: Full OU. • Slit lamp exam: megalocornea (>13 mm in diameter) and with anterior mosaic dystrophy. Iris-sutured posterior chamber IOLs (PCIOLs), stable OD, but pseudophacodonesis OS with loose inferior suture evident. • Dilated funduscopic exam: Normal OU Clinical Course: The patient’s iris-sutured IOL had become loose (tilted and de-centered) in his large anterior chamber, despite several sutures that had been placed in the past, resulting now in visual disturbance with movement. FDA and IRB approval was obtained to place an Artisan iris-clip IOL (Ophtec®). He was taken to the OR where his existing IOL was removed using Duet forceps and scissors. The Artisan IOL was placed using enclavation iris forceps. -
Long-Term Ocular Surface Stability in Conjunctival Limbal Autograft Donor Eyes
CLINICAL SCIENCE Long-Term Ocular Surface Stability in Conjunctival Limbal Autograft Donor Eyes Albert Y. Cheung, MD,*† Enrica Sarnicola, MD,*†‡ and Edward J. Holland, MD*† (OSST) procedures can provide healthy limbal stem cells Purpose: fi – To investigate the incidence of limbal stem cell de ciency and conjunctiva to rehabilitate a damaged ocular surface.2 8 (LSCD) in donor eyes after conjunctival limbal autograft (CLAU). Conjunctival limbal autograft (CLAU) is a technique that ; Methods: An observational retrospective review was performed on transplants a portion (typically 3to6clockhours)ofthe all patients who underwent CLAU alone, combined keratolimbal healthy stem cells from an unaffected eye to the contralat- allograft with CLAU (“Modified Cincinnati Procedure”), or com- eral affected eye in individuals affected by unilateral LSCD.6 bined living-related conjunctival limbal allograft (lr-CLAL) with 7 $ Cultivated limbal epithelial transplantation (CLET) CLAU having 6 months of follow-up after surgery. The outcome 8 measures were best-corrected visual acuity (BCVA) and ocular and simple limbal epithelial transplantation (SLET) provide surface status. ex vivo and in vivo expansion of stem cells, respectively, to repopulate the ocular surface. In contrast to CLET and SLET, Results: The inclusion criteria were fulfilled by 45 patients. Of CLAU is ideal for rehabilitating severe unilateral LSCD these, 26 patients underwent CLAU, 18 underwent combined requiring combined conjunctival limbal transplantation and keratolimbal allograft/CLAU, and 1 underwent combined lr- for reconstruction of the ocular surface. Proponents of CLET CLAL/CLAU. Mean age at the time of surgery was 39.6 years. and SLET have raised concerns regarding the potential Mean logMAR preoperative BCVA was 20.08. -
Managing Ocular Surface Inflammation”
E Y 7th EDITION OLOGIES OF THE E OLOGIES OF th H 7 AT EDITION P THEA INTERNATIONAL CONTEST OF CLINICAL CASES IN PATHOLOGIES OF THE EYE THEA INTERNATIONAL CONTEST OF CLINICAL CASES IN PATHOLOGIES OF THE EYE NTEST OF CLINICAL CASES IN OF CLINICAL NTEST O This brochure is produced under the sole responsibility of the authors. Laboratoires Théa are not involved in the writing of this document. This brochure may contain MA off-label and/or not validated by health authorities information. NATIONAL C NATIONAL R HEA INTE HEA T 2018 - 2019 EDITION 2018 - 2019 EDITION MANAGING MANAGING OCULAR SURFACE OCULAR SURFACE INFLAMMATION THE BEST CLINICAL CASES FROM 22 COUNTRIES INFLAMMATION THE BEST CLINICAL CASES FROM 22 COUNTRIES WWW.THEA-TROPHY.COM CLINICAL CASES CLINICAL - BA WTROBRO0120 WWW.THEA-TROPHY.COM Laboratoires Théa • 12, rue Louis Blériot 63017 Clermont-Ferrand Cedex 2 • France T +33 4 73 98 14 36 Laboratoires Théa F +33 4 73 98 14 38 LABORATOIRES-THEA.COM th 7 EDITION This brochure is produced under the sole responsibility of the authors, Laboratoires Théa are not involved in the writing of the clinical cases. This brochure may contain MA off-label and/or not validated by health authorities information. PREFACE Mr. JEAN-FRÉDÉRIC CHIBRET TROPHY 2018-2019 the Clinical Cases 2 M. Jean-Frédéric CHIBRET President of Laboratoires Théa Théa has focused its activities on research, development and commercialization of eye-care products, but at the same time has invested in education and knowledge promotion in line with the strong Chibret family tradition. In this way, Théa supports many projects and educational activities such as the European Meeting of Young Ophthalmologists (EMYO) or its partnership with the European Board of Ophthalmology (EBO). -
Recessive Buphthalmos in the Rabbit' Rochon-Duvigneaud
RECESSIVE BUPHTHALMOS IN THE RABBIT’ BERTRAM L. HANNA,2 PAUL B. SAWIN3 AND L. BENJAMIN SHEPPARD4 Received September 8, 1961 BUPHTHALMOS (hydrophthalmos, congenital infantile glaucoma) in rabbits has been of interest to European geneticists but has attracted little attention in the United States despite its recurrent appearance in laboratory and commercial breeding stocks. This condition is of particular interest to the field of expen- mental ophthalmology because of its similarity to congenital glaucoma in hu- mans. The earliest report of rabbit buphthalmos appears to be that of SCHLOESSER (1886), who presented the detailed histopathology of the left eye of a brown rab- bit which developed an acute glaucoma following irritation of both corneas to induce traumatic cataract. Other single case reports are by PICHLER(1910), ROCHON-DUVIGNEAUD(1921) and BECKH(1935), although in the last case the buphthalmos may have been secondary to a yaws infection. VOGT(1919), re- ported the occurrence of buphthalmos bilaterally in three siblings purchased at nine months of age. A mating between two of these produced a litter of three, all of which developed high grade buphthalmos. NACHTSHEIM(1937) and GERI (1954, 1955) studied the inheritance of buphthalmos and concluded that it is transmitted as an autosomal recessive trait. FRANCESCHETTI(1930) noted a de- ficiency of affected offspring from matings of heterozygous carrier parents. GERI (1955) found 12.5 percent affected offspring from carrier matings and suggested that the deficiency results from fetal death of buphthalmic animals. MCMASTER (1960) reported a mating of two animals with bilateral buphthalmos which pro- duced a litter of seven, only four of which were affected. -
Amniotic Membrane Grafts in Pediatric Corneal Limbal Dermoids with Conjunctival Eyelashes: a Case Presentation
Open Journal of Ophthalmology, 2016, 6, 191-197 http://www.scirp.org/journal/ojoph ISSN Online: 2165-7416 ISSN Print: 2165-7408 Amniotic Membrane Grafts in Pediatric Corneal Limbal Dermoids with Conjunctival Eyelashes: A Case Presentation Larisa Akah Che1, Linda A. Morgan2, Donny W. Suh2,3 1University of Nebraska Medical Center, Omaha, NE, USA 2Children’s Hospital & Medical Center, Omaha, NE, USA 3Department of Ophthalmology and Visual Sciences, Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE, USA How to cite this paper: Che, L.A., Morgan, Abstract L.A. and Suh, D.W. (2016) Amniotic Mem- brane Grafts in Pediatric Corneal Limbal Purpose: To report a case of a pediatric corneal limbal dermoid with eyelashes and Dermoids with Conjunctival Eyelashes: A to describe post-operative changes after excision with reconstruction using amniotic Case Presentation. Open Journal of Oph- membrane grafting, sutures and fibrinogen-thrombin glue. Case Report: One pedia- thalmology, 6, 191-197. http://dx.doi.org/10.4236/ojoph.2016.64027 tric patient was identified with a grade II infratemporal corneal-limbal dermoid with conjunctival eyelashes. The dermoid was surgically excised and the cornea recon- Received: August 23, 2016 structed with amniotic membrane using sutures and fibrinogen/thrombin glue. Pre- Accepted: October 11, 2016 operative and postoperative measurement of astigmatism, anisometropia and pres- Published: October 14, 2016 ence of exposure keratopathy were performed. Copyright © 2016 by authors and Scientific Research Publishing Inc. Keywords This work is licensed under the Creative Commons Attribution International Corneal Limbal Dermoid, Amniotic Membrane Graft, Choriostoma License (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/ Open Access 1. -
Transglutaminase in Ocular Health and Pathological Processes
perim Ex en l & ta a l ic O p in l h t C h f Journal of Clinical & Experimental a Tong et al. J Clinic Experiment Ophthalmol 2011, S:2 o l m l a o n l DOI: 10.4172/2155-9570.S2-002 r o g u y o J Ophthalmology ISSN: 2155-9570 ResearchResearch Article Article OpenOpen Access Access Recent Advances: Transglutaminase in Ocular Health and Pathological Processes Louis Tong1,2,3*, Evelyn Png2, Wanwen Lan2 and Andrea Petznick2 1Singapore National Eye Center, Singapore 2Singapore Eye Research Institute, Singapore 3Duke-NUS Graduate Medical School, Singapore Abstract Transglutaminase (TG) is a diverse class of crosslinking enzymes involved in the regulation of cytokine production, endocytosis, cell adhesion, migration, apoptosis and autophagy. It has been implicated in inflammatory diseases, neurodegenerative processes and cancer. The eye is a specialized organ which subserves the important function of vision and has distinctive physiological and anatomical properties that differ from other body tissues. Understanding of the roles of various TGs in the eye therefore require studies specific to cells and tissues of ocular origin. We review the advances in TG research in ocular diseases, including pterygium, glaucoma, cataract and proliferative vitreoretinopathy. TG1 is a molecule important for keratinisation in many cicatrizing diseases of the ocular surface, including keratoconjunctivitis sicca. TG2, with multiple functions, has been shown to be important in inflammation and cell adhesion in various ocular diseases. The results of TG research in each region of the eye are critically assessed and the implications of these studies in the treatment of ocular diseases are discussed. -
Ethical Issues in Living-Related Corneal Tissue Transplantation
Viewpoint Ethical issues in living-related corneal J Med Ethics: first published as 10.1136/medethics-2018-105146 on 23 May 2019. Downloaded from tissue transplantation Joséphine Behaegel, 1,2 Sorcha Ní Dhubhghaill,1,2 Heather Draper3 1Department of Ophthalmology, ABSTRact injury, typically chemical burns, chronic inflamma- Antwerp University Hospital, The cornea was the first human solid tissue to be tion and certain genetic diseases, the limbal stem Edegem, Belgium 2 transplanted successfully, and is now a common cells may be lost and the cornea becomes vascula- Faculty of Medicine and 5 6 Health Sciences, Dept of procedure in ophthalmic surgery. The grafts come from rised and opaque, leading to blindness (figure 1). Ophthalmology, Visual Optics deceased donors. Corneal therapies are now being In such cases, standard corneal transplants fail and Visual Rehabilitation, developed that rely on tissue from living-related donors. because of the inability to maintain a healthy epithe- University of Antwerp, Wilrijk, This presents new ethical challenges for ophthalmic lium. Limbal stem cell transplantation is designed to Belgium 3Division of Health Sciences, surgeons, who have hitherto been somewhat insulated address this problem by replacing the damaged or Warwick Medical School, from debates in transplantation and donation ethics. lost limbal stem cells (LSC) and restoring the ocular University of Warwick, Coventry, This paper provides the first overview of the ethical surface, which in turn increases the success rates of United Kingdom considerations generated by ocular tissue donation subsequent sight-restoring corneal transplants.7 8 from living donors and suggests how these might Limbal stem cell donations only entail the removal Correspondence to be addressed in practice. -
Ectopia Lentis: Weill Marchesani Syndrome
Review Articles Ectopia Lentis: Weill Marchesani Syndrome HL Trivedi*, Ramesh Venkatesh** Abstract A 20 yr old boy came to our OPD with decreased vision since 3 yrs. He complained of double vision in both the eyes. There were no other ocular or systemic complaints. On systemic exami- nation, the boy had a short stature compared to his age, short fingers and limbs. On ophthalmic examination, Vn in RE was 20/200 and LE was finger counting 5 ft. Cornea and other ocular adnexa were normal. The lens was spherical in shape and dislocated in the anterior chamber. There were no signs of iridocyclitis. Intraocular tension in both eyes was 20.6 mm Hg. Posterior segment evaluation was normal. Introduction of lens displacement. ctopia lentis is defined as displacement Frequency Eor malposition of the crystalline lens of the eye. The lens is considered dislocated or United States luxated when it lies completely outside the Ectopia lentis is a rare condition. Incidence lens patellar fossa, in the anterior chamber, in the general population is unknown. The free-floating in the vitreous, or directly on most common cause of ectopia lentis is the retina. The lens is described as subluxed trauma, which accounts for nearly one half when it is partially displaced but contained of all cases of lens dislocation. within the lens space. In the absence of Mortality/Morbidity trauma, ectopia lentis should evoke suspicion for concomitant hereditary systemic disease Ectopia lentis may cause marked visual disturbance, which varies with the degree of or associated ocular disorders. lens displacement and the underlying Weil Marchesani syndrome is also known aetiologic abnormality. -
Combined Trabeculotomy and Trabeculectomy: Outcome For
Eye (2011) 25, 77–83 & 2011 Macmillan Publishers Limited All rights reserved 0950-222X/11 $32.00 www.nature.com/eye 1 2 3 Combined VA Essuman , IZ Braimah , TA Ndanu and CLINICAL STUDY CT Ntim-Amponsah1 trabeculotomy and trabeculectomy: outcome for primary congenital glaucoma in a West African population Abstract Conclusion The overall success for combined trabeculotomy–trabeculectomy in Ghanaian Purpose To evaluate the surgical outcome of children with primary congenital glaucoma combined trabeculotomy–trabeculectomy in was 79%. The probability of success reduced Ghanaian children with primary congenital from more than 66% in the first 9 months glaucoma. postoperatively to below 45% after that. Materials and methods A retrospective case Eye (2011) 25, 77–83; doi:10.1038/eye.2010.156; series involving 19 eyes of 12 consecutive published online 5 November 2010 1Department of Surgery, children with primary congenital glaucoma University of Ghana Medical who had primary trabeculotomy– Keywords: primary congenital glaucoma; School, College of Health Sciences, University of trabeculectomy from 12 August 2004 to 30 June combined trabeculotomy–trabeculectomy; Ghana, Accra, Ghana 2008, at the Korle-Bu Teaching Hospital, intraocular pressure Ghana. Main outcome measures were 2Eye Unit, Department of preoperative and postoperative intraocular Surgery, Korle-Bu Teaching pressures, corneal diameter, corneal clarity, Introduction Hospital, Accra, Ghana bleb characteristics, duration of follow-up, surgical success, and complications. Primary congenital glaucoma (PCG) is a 3University of Ghana Dental Results A total of 19 eyes of 12 patients met hereditary childhood glaucoma resulting from School, College of Health the inclusion criteria. Six of the patients were abnormal development of the filtration angle, Sciences, University of Ghana, Accra, Ghana males. -
Clinical Manifestations of Congenital Aniridia
Clinical Manifestations of Congenital Aniridia Bhupesh Singh, MD; Ashik Mohamed, MBBS, M Tech; Sunita Chaurasia, MD; Muralidhar Ramappa, MD; Anil Kumar Mandal, MD; Subhadra Jalali, MD; Virender S. Sangwan, MD ABSTRACT Purpose: To study the various clinical manifestations as- were subluxation, coloboma, posterior lenticonus, and sociated with congenital aniridia in an Indian population. microspherophakia. Corneal involvement of varying degrees was seen in 157 of 262 (59.9%) eyes, glaucoma Methods: In this retrospective, consecutive, observa- was identified in 95 of 262 (36.3%) eyes, and foveal hy- tional case series, all patients with the diagnosis of con- poplasia could be assessed in 230 of 262 (87.7%) eyes. genital aniridia seen at the institute from January 2005 Median age when glaucoma and cataract were noted to December 2010 were reviewed. In all patients, the was 7 and 14 years, respectively. None of the patients demographic profile, visual acuity, and associated sys- had Wilm’s tumor. temic and ocular manifestations were studied. Conclusions: Congenital aniridia was commonly as- Results: The study included 262 eyes of 131 patients sociated with classically described ocular features. with congenital aniridia. Median patient age at the time However, systemic associations were characteristically of initial visit was 8 years (range: 1 day to 73 years). Most absent in this population. Notably, cataract and glau- cases were sporadic and none of the patients had par- coma were seen at an early age. This warrants a careful ents afflicted with aniridia. The most common anterior evaluation and periodic follow-up in these patients for segment abnormality identified was lenticular changes. -
Amniotic Membrane Transplantation for the Ocular Surface
Name of Blue Advantage Policy: Amniotic Membrane Transplantation for the Ocular Surface Policy #: 624 Latest Review Date: February 2021 Category: Medical Policy Grade: C BACKGROUND: Blue Advantage medical policy does not conflict with Local Coverage Determinations (LCDs), Local Medical Review Policies (LMRPs) or National Coverage Determinations (NCDs) or with coverage provisions in Medicare manuals, instructions or operational policy letters. In order to be covered by Blue Advantage the service shall be reasonable and necessary under Title XVIII of the Social Security Act, Section 1862(a)(1)(A). The service is considered reasonable and necessary if it is determined that the service is: 1. Safe and effective; 2. Not experimental or investigational*; 3. Appropriate, including duration and frequency that is considered appropriate for the service, in terms of whether it is: • Furnished in accordance with accepted standards of medical practice for the diagnosis or treatment of the patient’s condition or to improve the function of a malformed body member; • Furnished in a setting appropriate to the patient’s medical needs and condition; • Ordered and furnished by qualified personnel; • One that meets, but does not exceed, the patient’s medical need; and • At least as beneficial as an existing and available medically appropriate alternative. *Routine costs of qualifying clinical trial services with dates of service on or after September 19, 2000 which meet the requirements of the Clinical Trials NCD are considered reasonable and necessary by Medicare. Providers should bill Original Medicare for covered services that are related to clinical trials that meet Medicare requirements (Refer to Medicare National Coverage Determinations Manual, Chapter 1, Section 310 and Medicare Claims Processing Manual Chapter 32, Sections 69.0-69.11).